🇺🇸 FDA
Patent

US 8835167

Humanized anti-tag 72 CC49 for diagnosis and therapy of human tumors

granted A61KA61K2039/505A61K51/1045

Quick answer

US patent 8835167 (Humanized anti-tag 72 CC49 for diagnosis and therapy of human tumors) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Sep 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K2039/505, A61K51/1045, A61P, A61P35/00